A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia

Clinical trial NCT02226198 · COMPLETED

Trial details

NCT number: NCT02226198
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Homozygous Familial Hypercholesterolemia (HoFH)

Start date: 2014-11-01
Primary completion: 2015-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.